Caton, S. J., M. Bielohuby, Y. L. Bai, L. J. Spangler, L. Burget, P. Pfluger, C. Reinel, M. Czisch, M. Reincke, S. Obici, E. Kienzle, M. H. Tschöp and M. Bidlingmaier: Low-carbohydrate high-fat diets in combination with daily exercise in rats: Effects on body weight regulation, body composition and exercise capacity. In: Physiology & Behavior 106, 2, 185-192 (2012).
Dimopoulou, C., C. Sievers, M. Bidlingmaier and G. K. Stalla: A case of an acromegalic patient resistant to the recommended maximum GH receptor antagonist dosage. In: Hippokratia 16, 1, 80-82 (2012).
Roemmler, J., B. Steffin, B. Gutt, H. J. Schneider, C. Sievers, M. Bidlingmaier and J. Schopohl: The acute effect of a single application of cabergoline on endogenous GH levels in patients with acromegaly on pegvisomant treatment. In: Growth Hormone & IGF Research 20, 5, 338-344 (2010).
Bielohuby, M., K. Bodendorf, H. Brandstetter, M. Bidlingmaier and E. Kienzle: Predicting metabolisable energy in commercial rat diets: physiological fuel values may be misleading. In: British Journal of Nutrition 103, 10, 1525-1533 (2010).
Roemmler, J., B. Steffin, B. Gutt, H. J. Schneider, C. Sievers, M. Bidlingmaier and J. Schopohl: The acute effect of a single application of cabergoline on endogenous GH levels in patients with acromegaly on pegvisomant treatment. In: Experimental and Clinical Endocrinology & Diabetes 117, 10, 664-664 (2009).
Buchfelder, M., D. Weigel, M. Droste, K. Mann, B. Saller, K. Brubach, G. K. Stalla, M. Bidlingmaier and C. J. Strasburger: Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study. In: European Journal of Endocrinology 161, 1, 27-35 (2009).
Roemmler, J., B. Steffin, B. Gutt, C. Sievers, M. Bidlingmaier and J. Schopohl: The effect of acute application of pegvisomant alone and in combination with octreotide on endogenous GH levels during a 6-h test in patients with acromegaly on constant pegvisomant treatment. In: Growth Hormone & IGF Research 19, 3, 245-251 (2009).
Caton, S. J., L. J. Spangler, M. Bielohuby, C. Reinel, M. Czisch, J. Manolopoulou, Y. Bai, L. Burget, M. Tschoep and M. Bidlingmaier: Effects of a low-carbohydrate high-fat diet on body weight development, body composition and growth hormone/IGF-1 axis in rats. In: Experimental and Clinical Endocrinology & Diabetes 115, 8, 545-545 (2007).
Roemmler, J., B. Steffin, B. Gutt, C. Sievers, M. Bidlingmaier and J. Schopohl: Acute effect of the growth hormone antagonist pegvisomant injection alone and in combination with a somatostatin analogue on endogenous GH and pegvisomant levels. In: Experimental and Clinical Endocrinology & Diabetes 115, 8, 553-553 (2007).
Lob, S., J. Pickel, M. Bidlingmaier, L. Schaaf, H. Backmund, M. Gerlinghoff and G. K. Stalla: Serum leptin monitoring in anorectic patients during refeeding therapy. In: Experimental and Clinical Endocrinology & Diabetes 111, 5, 278-282 (2003).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.